(Q40448228)
Statements
1 reference
VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct. (English)
1 reference
Akseli Hemminki
1 reference
Tanja Hakkarainen
1 reference
Jarmo Wahlfors
1 reference
Tiina Wahlfors
1 reference
Outi Meriläinen
1 reference
Sami Loimas
1 reference
1 July 2005
1 reference
1 reference
7
1 reference
7
1 reference
898-907
1 reference
Identifiers
1 reference
1 reference